Overview

Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study

Status:
Unknown status
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this prospective randomized study is to determine whether patients on cardiac resynchronization therapy with concomitant long-standing persistent or permanent atrial fibrillation would benefit from a strategy to restore and maintain sinus rhythm (rhythm control strategy) in comparison to a rate control strategy in terms of higher biventricular paced beats percentage.
Phase:
Phase 4
Details
Lead Sponsor:
Institute of Cardiology, Warsaw, Poland
Treatments:
Adrenergic beta-Antagonists
Amiodarone